ELVALHALCOR S.A (CR)/ GRS281003004 /
| 2024-05-14 12:00:00 AM | Chg. -0.02 | Volume | Bid4:12:27 PM | Ask4:12:27 PM | High | Low |
|---|---|---|---|---|---|---|
| 1.98EUR | -1.10% | 110,945 Turnover: 219,710.05 |
1.98Bid Size: - | 1.98Ask Size: - | 2.00 | 1.97 |
GlobeNewswire
1:03 PM
Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National ...
GlobeNewswire
1:01 PM
Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presente...
GlobeNewswire
1:00 PM
BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024
GlobeNewswire
1:00 PM
Edible Garden Reports Significant 27.6% Year-Over-Year Revenue Growth for First Quarter of 2024
GlobeNewswire
1:00 PM
Dorman Products expands its catalog of cost-saving and aftermarket-exclusive repair solutions
GlobeNewswire
1:00 PM
Plug to Revolutionize Middle-Mile Delivery with Class 6 Fuel Cell Electric Truck Integration
GlobeNewswire
1:00 PM
Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
1:00 PM
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
GlobeNewswire
1:00 PM
Boralex announces a substantial 62% increase in net earnings and continued disciplined development o...
GlobeNewswire
1:00 PM
T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
1:00 PM
TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the ...
GlobeNewswire
1:00 PM
Creative Realities Inc. plans its expansion into EMEA and announces its beta launch to EMEA Integrat...
